K.C. Pharmaceuticals Recalls 3.1 Million Eye Drops

K.C. Pharmaceuticals, a manufacturer based in Pomona, California, has voluntarily recalled more than 3.1 million bottles of over-the-counter eye drops distributed nationwide due to concerns over sterility in the manufacturing process, federal health officials announced in late March.

The U.S. Food and Drug Administration classified the recall as Class II, indicating that use of the products may cause temporary or medically reversible health problems or carry a remote probability of serious adverse effects. The action, initiated by the company on March 3, affects eight types of lubricant and redness-relief eye drops sold in 0.5-fluid-ounce bottles under various store-brand names. No illnesses or injuries have been reported in connection with the products so far, according to FDA records.

The recalled items include 1,023,096 bottles of Dry Eye Relief Eye Drops containing glycerin, hypromellose and polyethylene glycol; 589,848 bottles of Artificial Tears Sterile Lubricant Eye Drops with polyvinyl alcohol and povidone; 378,144 bottles of Sterile Eye Drops Original Formula featuring tetrahydrozoline hydrochloride; and smaller quantities of five other variants, such as Sterile Eye...